Dr Lalchand. Lab

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE871Z01013
  • NSEID:
  • BSEID: 541299
INR
9.38
0.21 (2.29%)
BSENSE

Jun 10, 03:30 PM

BSE+NSE Vol: 8000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002986,
    "name": "Dr Lalchand. Lab",
    "stock_name": "Dr Lalchand. Lab",
    "full_name": "Dr Lalchandani Labs Ltd",
    "name_url": "stocks-analysis/dr-lalchand-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.38",
    "chg": 0.21,
    "chgp": "2.29%",
    "dir": 1,
    "prev_price": "9.17",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541299,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE871Z01013",
    "curr_date": "Jun 10, 03:30 PM",
    "curr_time": "05:01 AM",
    "last_traded_at": "Jun 10, 03:30 PM IST",
    "bse_nse_vol": 8000,
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lalchand-lab-1002986-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 53,
    "sid": "1002986",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lalchandani-labs-1002986"
  },
  "announcements": [
    {
      "caption": "Approval Of Audited Financial Results For The Half Year And Year Ended March 31 2026",
      "datetime": "03-Jun-2026",
      "details": "Audited Financial Results for the half year and year ended March 31 2206",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 31 2026",
      "datetime": "03-Jun-2026",
      "details": "Audited Financial Results for the quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
      "datetime": "30-May-2026",
      "details": "Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lalchandani Labs Ltd has announced <strong>1:1</strong> rights issue, ex-date: 27 Jan 26",
          "dt": "2026-01-27",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Approval Of Audited Financial Results For The Half Year And Year Ended March 31 2026

03-Jun-2026 | Source : BSE

Audited Financial Results for the half year and year ended March 31 2206

Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 31 2026

03-Jun-2026 | Source : BSE

Audited Financial Results for the quarter and year ended March 31 2026

Announcement under Regulation 30 (LODR)-Meeting Updates

30-May-2026 | Source : BSE

Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Dr Lalchandani Labs Ltd has announced 1:1 rights issue, ex-date: 27 Jan 26